{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:42:27Z","timestamp":1787071347623,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,1]]},"abstract":"\n Context:<\/jats:title>\n This study was done to assess the Serial peripheral blood and bone marrow changes in patients of Acute Lymphoblastic Leukemia on chemotherapy.<\/jats:p>\n <\/jats:sec>\n \n Aims:<\/jats:title>\n To assess the therapy related serial bone marrow changes in patients of Acute Lymphoblastic Leukemia.<\/jats:p>\n <\/jats:sec>\n \n Settings and Design:<\/jats:title>\n Prospective study, carried out in Lymphoma- Leukemia Lab, Department of Pathology, K.G.M.U from March 2011 to March 2012. A total of 60 cases were studied<\/jats:p>\n <\/jats:sec>\n \n Materials and Methods:<\/jats:title>\n History, complete hemogram, bone marrow examination at pretherapy (Day-0), intratherapy (Day-14), and end of induction chemotherapy (Day-28) were done. Peripheral blood smears were evaluated at regular interval to assess clearance of blast cells.<\/jats:p>\n <\/jats:sec>\n \n Statistical analysis used:<\/jats:title>\n \n The statistical analysis was done using SPSS (Statistical Package for Social Sciences) Version 15.0 statistical Analysis Software. The values were represented in Number (%) and Mean \u00b1 SD. The following Statistical formulas were used: Mean, standard deviation, Chi square test, Paired \u201ct\u201d test, Student 't' test, Level of significance\n P<\/jats:italic>\n <\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n Incidence of ALL-L1 (46.7%) and ALL-L2 (53.3%) was equal. ALL-L2 patients had poor survival. Day 0 (D-0) bone marrow was hypercellular with flooding of marrow by leukemic cells. High levels of tumor load at D'0' were associated with poor survival. 14\n th<\/jats:sup>\n day of Induction phase showed significant decrease in hemoglobin and TLC as compared to D '0' parameters. D28 showed marrow regeneration. Cellularity, Blast%, and Leukemic Index showed significant drop from day '0' to day 14 due to myelosupression, whereas regeneration reflected by increased cellularity as per day 28 marrow. Lymphocytosis (>20%) at end of induction chemotherapy had better survival and longer remission. Risk of mortality was directly proportional to blast clearance and was a major independent prognostic factor for achievement of complete remission.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions:<\/jats:title>\n A bone marrow examination at the end of induction chemotherapy provides information whether patient has achieved remission with regeneration of cells or still has residual leukemia. If the patient is in remission, maintenance treatment is started and if not more intensive chemotherapy or bone marrow transplantation may be embarked upon.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/0377-4929.130903","type":"journal-article","created":{"date-parts":[[2014,4,28]],"date-time":"2014-04-28T09:02:49Z","timestamp":1398675769000},"page":"72-77","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Post chemotherapy blood and bone marrow regenerative changes in childhood acute lymphoblastic leukemia a prospective study"],"prefix":"10.4103","volume":"57","author":[{"given":"Rashmi","family":"Kushwaha","sequence":"first","affiliation":[{"name":"Department of Pathology, K.G.M.U, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Pathology, K.G.M.U, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Aggrawal","sequence":"additional","affiliation":[{"name":"Department of Pathology, K.G.M.U, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Nigam","sequence":"additional","affiliation":[{"name":"Department of Pathology, K.G.M.U, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, K.G.M.U, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250922","first-page":"3","article-title":"childhood acute lymphoblastic leukemia: Indian experience","volume":"24","author":"Bhutani","year":"2003","journal-title":"Indian J Med Pediatr Oncol"},{"key":"R2-20250922","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJM199806043382304","article-title":"Augmented post induction therapy for children with high risk acute lymphoblastic leukemia and a slow response to initial therapy","volume":"338","author":"Nachman","year":"1998","journal-title":"N Engl J Med"},{"key":"R3-20250922","first-page":"3310","article-title":"Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: Results of trial ALL-BFM 90","volume":"95","author":"Schrappe","year":"2000","journal-title":"German-Austrian-Swiss ALL-BFM Study Group. Blood"},{"key":"R4-20250922","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra052603","article-title":"Treatment of acute lymphoblastic leukemia","volume":"354","author":"Pui","year":"2006","journal-title":"N Engl J Med"},{"issue":"Suppl 4","key":"R5-20250922","first-page":"54","article-title":"Why is age such an important independent prognostic factor in acute lymphoblastic leukemia","volume":"11","author":"Perentesis","year":"1997","journal-title":"Leukemia"},{"key":"R6-20250922","first-page":"24","article-title":"Acute lymphoblastic leukemia in adults: Recent progress, future directions","author":"Hoelzer","year":"1987","journal-title":"Semin Hematol"},{"key":"R7-20250922","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1055\/s-2005-872515","article-title":"Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: Data from the trials ALL-BFM 86, 90, and 95","volume":"217","author":"M\u00f6ncke","year":"2005","journal-title":"Klin Pediatr"},{"key":"R8-20250922","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1634\/theoncologist.5-4-321","article-title":"The role of prognostic features in the treatment of childhood acute lymphoblastic leukemia","volume":"5","author":"Alison","year":"2000","journal-title":"Oncologist"},{"key":"R9-20250922","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/adc.61.10.1007","article-title":"Acute Lymphoblastic Leukemia under 2 years","volume":"61","author":"Leiper","year":"1986","journal-title":"Arch Dis Child"},{"key":"R10-20250922","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/1097-0142(19830315)51:6<1041::AID-CNCR2820510612>3.0.CO;2-G","article-title":"Prognostic factors and therapy in Acute lymphoblastic leukemias of childhood (CG 14)","volume":"5","author":"Miller","year":"1983","journal-title":"Cancer"},{"key":"R11-20250922","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1749-6632.1984.tb12280.x","article-title":"Pediatric oncology group utilization of immunologic markers in the designation of acute lymphoblastic leukemia (ALL) subgroups","volume":"428","author":"Pullen","year":"1984","journal-title":"Influence on treatment response. Ann N Y Acad Sci"},{"key":"R12-20250922","first-page":"105","article-title":"Immunologic markers in childhood acute lymphoblastic leukemia","volume":"12","author":"Crist","year":"1985","journal-title":"Semin Oncol"},{"key":"R13-20250922","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1182\/blood.V75.1.174.174","article-title":"Heterogeneity of presenting features and their relation to treatment outcome in 120 childrens with T-cell acute lymphoblastic leukemia","volume":"75","author":"Pui","year":"1990","journal-title":"Blood"},{"key":"R14-20250922","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1055\/s-2007-1025528","article-title":"Incidence, clinical markers and prognostic significance of immunological subtypes of acute lymphoblastic leukemia (ALL) in children: Experiences of the ALL-BFM 83 and 86 studies","volume":"202","author":"Ludwig","year":"1990","journal-title":"Klin Padiatr"},{"key":"R15-20250922","first-page":"903","article-title":"Childhhod acute leukemia in West Bengal, India","volume":"10","author":"Biswas","year":"2009","journal-title":"Asian Pac J Cancer Prev"},{"key":"R16-20250922","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1182\/blood.V67.6.1688.1688","article-title":"Cytogenetic features and serum lactate dehydrogenase level predicts a poor treatment outcome for children with pre B cell leukemia","volume":"67","author":"Pui","year":"1986","journal-title":"Blood"},{"key":"R17-20250922","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1182\/blood.V56.3.351.351","article-title":"serum lactate dehydrogenase (LDH) levels in acute leukemia: Marked elevations in lymphoblastic leukemia","volume":"56","author":"Kornberg","year":"1980","journal-title":"Blood"},{"key":"R18-20250922","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3329\/bmrcb.v33i3.1139","article-title":"Serum lactate dehydrogenase level in childhood acute lymphoblastic leukemia","volume":"33","author":"Hafiz","year":"2007","journal-title":"Bangladesh Med Res Counc Bull"},{"key":"R19-20250922","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/mpo.2950180405","article-title":"Renal dysfunction and hyperuricemia at presentation and relapse of acute lymphoblastic leukemia","volume":"18","author":"Jones","year":"1990","journal-title":"Med Pediatr Oncol"},{"key":"R20-20250922","first-page":"817","article-title":"Bone marrow biopsy during induction chemotherapy for Acute myeloid leukemia identifies only 50% of patients with resistant disease","volume":"12","author":"Roberts","year":"1988","journal-title":"LeukRes"},{"key":"R21-20250922","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2141.1980.tb07175.x","article-title":"Histological Study of Bone marrow regeneration following chemotherapy for Acute myeloid Leukemia and chronic granulocytic leukemia in Blast transformation","volume":"45","author":"Islam","year":"1980","journal-title":"Br J Haematel"},{"key":"R22-20250922","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1182\/blood.V71.4.989.989","article-title":"Slow disappearance of peripheral blast cells: An independent risk factor indicating poor prognosis in children with acute lymphoblastic leukemia","volume":"71","author":"Rautonen","year":"1988","journal-title":"Blood"},{"key":"R23-20250922","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1182\/blood.V86.4.1292.bloodjournal8641292","article-title":"Persistence of Circulating Blasts After 1 Week of Multiagent Chemotherapy Confers a Poor Prognosis in Childhood Acute Lymphoblastic Leukemia","volume":"86","author":"Gajjar","year":"1995","journal-title":"Blood"},{"key":"R24-20250922","first-page":"10","article-title":"Absolute Lymphocyte Count as a prognostic factor in children with acute lymphoblastic leukemia","volume":"76","author":"Anoceto Mart\u00ednez","year":"2012","journal-title":"An Pediatr (Barc)"},{"key":"R25-20250922","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/cncr.23168","article-title":"Absolute Lymphocyte count is a novel prognostic indicator in ALL and AML","volume":"112","author":"De Angulo","year":"2008","journal-title":"Cancer"},{"key":"R26-20250922","first-page":"957","article-title":"Absolute lymphocyte count at day 28 independently predicts event free and overall survival in adults with newly diagnosed acute lymphoblastic leukemia","volume":"87","author":"Sun","year":"2012","journal-title":"AmJHematol"}],"container-title":["Indian Journal of Pathology and Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004270-201457010-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:44:44Z","timestamp":1787067884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004270-201457010-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.4103\/0377-4929.130903","relation":{},"ISSN":["0377-4929","0974-5130"],"issn-type":[{"value":"0377-4929","type":"print"},{"value":"0974-5130","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}